Skip to content
Search

Latest Stories

Continuing royal legacy: RPS appoints King Charles as new patron

Continuing royal legacy: RPS appoints King Charles as new patron

King Charles's patronage signals a new era of support for the RPS's mission to advance healthcare and patient-well being 

In a recent announcement, King Charles has agreed to become a patron of the society at Royal Pharmaceutical Society (RPS) following the footsteps of the late Queen.

Buckingham Palace confirmed the news, marking the first anniversary of the Coronation of His Majesty The King and Her Majesty The Queen.


This prestigious appointment comes after a meticulous evaluation of over 1000 Patronages, previously held by The late Queen, The former Prince of Wales, and The former Duchess of Cornwall.

The decision underscores His Majesty's commitment to supporting organisations dedicated to advancing healthcare and patient well-being.

The RPS has a rich history of association with the Royal Family, notably with The late Queen, who served as patron from 1953 until her passing in 2022.

Additionally, her father, George VI, held the position of Patron from 1937 to 1952.

Now, with His Majesty The King as the new Patron, this tradition of royal patronage continues to flourish.

Expressing immense pride and gratitude, Professor Claire Anderson, President of RPS, remarked, "We are hugely proud that His Majesty The King has chosen to be our patron, following in the footsteps of The late Queen and her father, George VI."

"We are grateful to the Royal Family for their ongoing support."

Echoing this sentiment, RPS Chief Executive Paul Bennett stated, "It is an honour to have His Majesty The King as our new Royal Patron."

"We look forward to continuing our work to highlight the vital contribution pharmacy teams make to patient care across Great Britain with the patronage of His Majesty."

With His Majesty The King's patronage, the RPS is poised to embark on new initiatives and endeavors, further cementing its position as a leading advocate for pharmacy professionals and the patients they serve.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less